JANX · Company research
Janux Therapeutics, Inc. (JANX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 17.92 | $1,043,500,351.1 | 1015732351.10 | — | — | — | 101.6363447063407032 | 1.1244809728400490 | 84.96176120338707050855 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.